
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ANNA; anti-neuronal nuclear antibody; APS; antiphospholipid syndrome; ARHGAP26; Ca/RhoGTPase-activating protein 26; CaMKII; calcium calmodulin-dependent protein kinase II; CASPR2; contactin-asso